Cytocore Inc (CYOE) Annual Income Statement

Annual · GAAP · USD millions
Access CYOE quarterly income statements →
Income statement data covering Cytocore Inc– offers a view into how Dec 31 2013's operating results have moved alongside business activity.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CYOE/income-statements
https://api.csimarket.com/api/v1/companies/CYOE/fundamentals
https://api.csimarket.com/api/v1/companies/CYOE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2013)
2013
(Dec 31 2012) (Dec 31 2011)
Revenues
Total Revenue9.96
Costs & Expenses
Cost of Goods and Services Sold5.75
Gross Profit0.02
Selling, Administration, Marketing0.58
Depreciation & Amortization0.20
Research and Development Expense0.93
Restructuring, Accretion & Impairment Charges0.00
Other Operating Expense / -Income0.00
Total operating costs including COS9.66
Operating income / -loss0.29
Interest Expense0.10
Interest Income0.05
Net Interest (-)Expense / Income-0.31
Extinguishment of Debt0.21
Loss / -Gain on Investment0.05
Other loss / -income0.10
Total costs & expenses9.66
Income & Taxes
Income / -loss before income taxes0.07
Income taxes expenses / -benefit0.05
Income after income taxes0.05
Income / -loss from continuing operations0.05
Preferred dividends0.00
Net income / -loss0.05
Income / -loss to shareholder0.05
EBIT0.39
EBITD0.44
EBITDA0.44
Earnings Per Share
Basic EPS (excl. extra items)-0.01
Basic Net EPS-0.01
Basic shares outstanding (Mill. of Units)146.88
Diluted Net EPS-0.01
Diluted average shares (Mill. of Units)146.88
4 historic quarters locked

Sign in to unlock the full Cytocore Inc income statement history.

About CYOE Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI